قائمة الدراسات السريرية المسجلة على الادوية

مشاركة الصفحة

عرض 321 - 330 من 443
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
An Observational, Cross-sectional Study on the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in adult Population within the MENA Region. GSK Ongoing N/A 4 Version 2.1 - 30/08/2009 Prince Sultan Military Medical City (Riyadh)
Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) GSK Ongoing Lapatinib / Capecitabine 4 113780 King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah)
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 Roche Ongoing Pegasys 3 ML22728 King Abdulaziz Medical City NG (Riyadh)
Prevalence of Cardiovascular Risk Factors in Patients Attending General Practice Clinics in Selected Countries in the Africa and The Middle East : AFME Cardiovascular Epidemiology (ACE) Study. Pfizer Ongoing N/A 4 A2581186 Dallah Hospital (Riyadh), Al Mana General Hospital (Khobar), University District Hospital (Jeddah), Al Shifa Medical Hospital (Makkah)
An observational study to evaluate caregiver's preference and treatment outcome in patient with alzheimer's disease treated with oral or tramsdermal monotheraby - Real-World Evaluation of compliance and preference in the treatment of Alzheimer's disease(RECAP). Novartis Ongoing Rivastigmine 4 CENA713D-MAX-SA-01 Dr. Soliman Fakeeh Hospital (Jeddah)
Changing Diabetes® World Tour Novonordisk Ongoing N/A 4 version 6 - October 2010 King Abdulaziz University Hospital (Jeddah)
A Prospective Observational Study on the home treatment of haemarthrosis with VIIa (activated recombinant factor VII) in haemophilia A and B patient with inhibitors Novonordisk Ongoing NovoSeven (activated recombinant factor VII) 4 F7HEAM-3850 King Khalid University Hospital (Riyadh)
DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002 AstraZeneca Ongoing N/A 4 D1690R0000 King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah)
Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients Sanofi Ongoing N/A 4 2 King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh)
A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia Tabuk Pharmaceuticals Ongoing NERVAX 4 N-001 King Fahad Medical City (Riyadh)


هل استفدت من ما هو مقدم في هذه الصفحة؟
0 من الزوار ردوا بنعم من أصل0 مشاركة
السبب
السبب